Focus on an unusual rise in pancreatic cancer incidence in France
- PMID: 28605500
- PMCID: PMC5837593
- DOI: 10.1093/ije/dyx088
Focus on an unusual rise in pancreatic cancer incidence in France
Abstract
Background: Pancreatic cancer is one of the most lethal. Most countries have exhibited a stable or decreasing incidence over time. The aim of this study was to provide updated French temporal trends in pancreatic cancer incidence and mortality over the past three decades.
Methods: Incidence was estimated using the French National Network of Cancer Registries (FRANCIM) and mortality using the French Mortality Statistics Office. World age-standardized incidence and mortality were modelled by age-period-cohort models. The net cumulative risk of developing pancreatic cancer by birth cohort was calculated, as were annual percentage changes (APCs) in incidence and mortality.
Results: Between 1982 and 2012, age-standardized incidence increased from 4.8 in 1980 to 9.6 per 100 000 in men and from 2.3 to 6.8 in women. The mean APC was 2.3% (2.1-2.6) and 3.6% (3.3-3.9), respectively. The cumulative risk of developing pancreatic cancer before age 75 rose from 0.62% for males born around 1920 to 1.17% for those born around 1950. It was respectively 0.31% and 0.86% for women. Mortality did not vary in men (8.1 per 100 000). It slightly increased in women from 4.0 in 1982 to 5.4 in 2012.
Conclusion: Pancreatic cancer incidence and mortality exhibited diverging trends. Incidence increased over the last 30 years in France whereas mortality did not vary in men and moderately increased in women. Incidence remained lower than mortality up to 2002. One cannot exclude the possibility that a similar trend may appear in other countries. Etiological studies are required to further explain this increase.
Keywords: cancer registry; epidemiology; incidence; mortality; pancreatic cancer.
© The Author 2017; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association
Figures
Comment in
-
Pancreatic cancer incidence rises also in Italy.Int J Epidemiol. 2017 Dec 1;46(6):2090. doi: 10.1093/ije/dyx197. Int J Epidemiol. 2017. PMID: 29024994 No abstract available.
-
Commentary: Unusual pancreatic cancer incidence and mortality patterns.Int J Epidemiol. 2017 Dec 1;46(6):1772-1773. doi: 10.1093/ije/dyx142. Int J Epidemiol. 2017. PMID: 29025013 No abstract available.
-
Commentary: Pancreatic cancer: is the worst to come?Int J Epidemiol. 2017 Dec 1;46(6):1774-1775. doi: 10.1093/ije/dyx143. Int J Epidemiol. 2017. PMID: 29025067 No abstract available.
-
Commentary: A pancreatic cancer incidence and mortality gap?Int J Epidemiol. 2017 Dec 1;46(6):1775-1776. doi: 10.1093/ije/dyx144. Int J Epidemiol. 2017. PMID: 29025091 No abstract available.
References
-
- Ferlay J, Soerjomataram I, Ervik M. et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon: International Agency for Research on Cancer, 2013.
-
- Howlader N, Noone AM, Krapcho M. et al. SEER Cancer Statistics Review, 1975–2012, National Cancer Institute. SEER Cancer Statistics Review, 1975–2013, National Cancer Institute. Bethesda, MD, 2016. http://seer.cancer.gov/csr/1975_2013/ (28 April 2017, date last accessed).
-
- Lepage C, Capocaccia R, Hackl M. et al. Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: results of EUROCARE-5. Eur J Cancer 2015;51:2169–78. - PubMed
-
- Coleman M, Esteve J, Damiecki P. et al. Trends in Cancer Incidence and Mortality, IARC ed. Lyon: Scientific Publication, 1993. - PubMed
-
- Bouvier AM, David M, Jooste V. et al. Rising incidence of pancreatic cancer in France. Pancreas 2010;39:1243–6. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
